leadf
logo-loader
viewNaturally Splendid Enterprises Ltd.
(
TSX-V:NSPOTC:NSPDF
)

Naturally Splendid provides data after receiving Health Canada Information request

Naturally Splendid (CVE: NSP- OTCPINK: NSPDF) CEO Craig Goodwin joined Steve Darling from Proactive to share news the company has responded to Health Canada's Information Request Notice. The IRN was designed to determine the final dosage of Cavaltinib intended for use as a COVID treatment and to define the final criteria for the selection of patients making up the test and control groups for the trial.

Goodwin talks about this step in the process and of they have been given any timelines from Health Canada.

Quick facts: Naturally Splendid Enterprises Ltd.

Follow
TSX-V:NSP

Price: 0.045 CAD

Market Cap: $9.81 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Naturally Splendid’s Natera Plant-based products will offer select products...

Naturally Splendid CEO Craig Goodwin joined Steve Darling from Proactive to share details that the company’s test run with Denny’s Restaurant has gone well and now a select number of their products will now be featured at 71 Denny's across Canada starting later this fall. Goodwin also told...

3 weeks, 6 days ago

2 min read